Osmel P Alvarez, David Monroy, Soraiya Thura, Michael Antonietti, Sohaib Fasih-Ahmad, Paula A Sepulveda-Beltran, Sara Culbertson, Sander R Dubovy, Anat Galor, Carol L Karp
{"title":"Infectious etiologies of conjunctival tumors.","authors":"Osmel P Alvarez, David Monroy, Soraiya Thura, Michael Antonietti, Sohaib Fasih-Ahmad, Paula A Sepulveda-Beltran, Sara Culbertson, Sander R Dubovy, Anat Galor, Carol L Karp","doi":"10.1080/17469899.2024.2396926","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Infectious agents have been associated with a variety of conjunctival tumors, including lymphoma, ocular surface squamous neoplasia (OSSN), papilloma, and Kaposi sarcoma.</p><p><strong>Areas covered: </strong>We discuss the infectious etiologies of certain conjunctival tumors including conjunctival lymphoma (<i>Chlamydia</i> spp. <i>Helicobacter pylori</i>, Epstein-Barr virus, hepatitis C virus), OSSN (human papillomavirus, human immunodeficiency virus), papilloma (human papilloma virus), and Kaposi sarcoma (Kaposi sarcoma herpesvirus). Their respective oncogenic mechanisms, diagnosis, and treatment options are reviewed.</p><p><strong>Expert opinion: </strong>It is important for the clinician to recognize when tumors of the conjunctiva may be infection-associated. A detailed history and exam are the most important first step in diagnosis; this may be supplemented by tools such as high-resolution optical coherence tomography. For some tumors, the specific causative agent may influence treatment options and outcomes. For others, data suggest the infectious agent does not influence treatment or outcomes, but it is important nonetheless to be aware as further research on these tumors continues. Additionally, there is exciting research investigating novel and minimally invasive diagnostic and treatment options for conjunctival tumors, including treatments that target the infectious agent directly.</p>","PeriodicalId":39989,"journal":{"name":"Expert Review of Ophthalmology","volume":"20 1","pages":"3-18"},"PeriodicalIF":0.9000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12506805/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/17469899.2024.2396926","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/11 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Infectious agents have been associated with a variety of conjunctival tumors, including lymphoma, ocular surface squamous neoplasia (OSSN), papilloma, and Kaposi sarcoma.
Areas covered: We discuss the infectious etiologies of certain conjunctival tumors including conjunctival lymphoma (Chlamydia spp. Helicobacter pylori, Epstein-Barr virus, hepatitis C virus), OSSN (human papillomavirus, human immunodeficiency virus), papilloma (human papilloma virus), and Kaposi sarcoma (Kaposi sarcoma herpesvirus). Their respective oncogenic mechanisms, diagnosis, and treatment options are reviewed.
Expert opinion: It is important for the clinician to recognize when tumors of the conjunctiva may be infection-associated. A detailed history and exam are the most important first step in diagnosis; this may be supplemented by tools such as high-resolution optical coherence tomography. For some tumors, the specific causative agent may influence treatment options and outcomes. For others, data suggest the infectious agent does not influence treatment or outcomes, but it is important nonetheless to be aware as further research on these tumors continues. Additionally, there is exciting research investigating novel and minimally invasive diagnostic and treatment options for conjunctival tumors, including treatments that target the infectious agent directly.
期刊介绍:
The worldwide problem of visual impairment is set to increase, as we are seeing increased longevity in developed countries. This will produce a crisis in vision care unless concerted action is taken. The substantial value that ophthalmic interventions confer to patients with eye diseases has led to intense research efforts in this area in recent years, with corresponding improvements in treatment, ophthalmic instrumentation and surgical techniques. As a result, the future for ophthalmology holds great promise as further exciting and innovative developments unfold.